BioPharmSignal logoBioPharmSignal

Biotech News

Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity

UnitedHealth Group (UNH)UnitedHealth Group2026-04-14 12:00 ESTCompany update

UNH (UNH) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is unh.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

UNHUnitedHealth Group2026-07-06 12:00 EST

Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

UNHUnitedHealth Group2026-05-26 11:00 EST

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

UNHUnitedHealth Group2026-05-21 12:00 EST

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

UNHUnitedHealth Group2026-05-14 12:00 EST

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

UNHUnitedHealth Group2026-05-13 11:00 EST

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

UNHUnitedHealth Group2026-05-12 12:00 EST

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

UNHUnitedHealth Group2026-05-05 12:00 EST

Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026

UNHUnitedHealth Group2026-04-22 12:00 EST

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

UNHUnitedHealth Group2026-04-07 12:00 EST

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer

UNHUnitedHealth Group2026-03-18 12:00 EST

Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit

View all latest news

UnitedHealth Group

UnitedHealth Group is a diversified healthcare company with insurance, care delivery, and services operations through UnitedHealthcare and Optum. The company’s story is driven more by managed-care scale, services growth, and operating execution than by classic biotech catalysts.

Recent company news

UNHBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

UNHQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

UNHMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

UNHAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

UNHGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close
423.56 USD
Market cap
343.21B USD
Exchange
NYSE
Sector
Healthcare Services
Location
United States